HomeNewsBusinessReal EstateBuild and Sell homes: Is it the end of the road for off-the-shelf homes?
Trending Topics

Build and Sell homes: Is it the end of the road for off-the-shelf homes?

While the housing segment is gradually gaining momentum, experts are of the view that the pure Build and Sell model may not gain foothold.

March 16, 2021 / 10:12 IST
Story continues below Advertisement

Four years back, after the implementation of RERA, a new homebuyer-friendly business model Build and Sell emerged in the real estate sector. But, COVID-19 played spoilsport.

Globally, the concept of off-the-shelf homes has been in existence for several years. However, in India developers could not adopt the build and sell model as land has historically been expensive and forms a major portion of the project cost. Moreover, with land buying not being funded by banks, construction finance from banks and NBFCs drying up , developers have to settle for expensive capital from private lenders.

Story continues below Advertisement

This model, it should be noted, took root after RERA was implemented in May 2017.

Real estate major DLF Limited initiated the concept. Under RERA, developers were barred from launching any project without registration and regulatory approvals in place. So, before launching any project, they were required to buy land and incur regulatory compliance cost that included acquiring licenses for the project.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show